MeiraGTx Holdings plc
MGTX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001735438
In the last 90 days, MeiraGTx Holdings plc insiders filed 0 open-market purchases and 3 sales; 158 institutions reported holding it in 13F filings for Q2 2026, worth $1.07B in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in MeiraGTx Holdings plc as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 103
- +4 vs. Q4 2021
- Shares held
- 29.3M
- +920.5K (+3.2%) vs. Q4 2021
- Total value
- $405.7M
- −$267.2M (−39.7%) vs. Q4 2021
- New holders
- 18
- 32 more added
- Sold out
- 14
- 31 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MGTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 158 | $1.07B |
| Q1 2026 | 133 | $583.0M |
| Q4 2025 | 130 | $518.2M |
| Q3 2025 | 123 | $527.6M |
| Q2 2025 | 112 | $419.6M |
| Q1 2025 | 118 | $406.7M |
| Q4 2024 | 102 | $353.9M |
| Q3 2024 | 99 | $188.6M |
| Q2 2024 | 95 | $170.4M |
| Q1 2024 | 96 | $238.5M |
| Q4 2023 | 86 | $275.1M |
| Q3 2023 | 75 | $185.6M |
| Q2 2023 | 79 | $253.6M |
| Q1 2023 | 92 | $148.6M |
| Q4 2022 | 99 | $193.0M |
| Q3 2022 | 100 | $234.5M |
| Q2 2022 | 108 | $216.1M |
| Q1 2022 | 103 | $405.7M |
| Q4 2021 | 99 | $672.9M |
| Q3 2021 | 81 | $367.3M |
| Q2 2021 | 80 | $433.5M |
| Q1 2021 | 81 | $384.8M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding MeiraGTx Holdings plc; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Adage Capital Partners GP, L.L.C. | 2,972,155 | $41.2M | 0.08% | +109,101+3.8% | Added |
| OrbiMed Advisors LLC | 3,296,666 | $45.7M | 0.74% | −430,800−11.6% | Reduced |
| Perceptive Advisors LLC | 6,948,277 | $96.2M | 2.00% | 00.0% | Unchanged |
| Zacks Investment Management | 0 | $0 | 0.00% | −21,017−100.0% | Sold out |
| Bailard, Inc. | 0 | $0 | 0.00% | −15,400−100.0% | Sold out |
| Parametric Portfolio Associates LLC | 0 | $0 | 0.00% | −14,208−100.0% | Sold out |
| Corton Capital Inc. | 0 | $0 | 0.00% | −11,140−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −9,004−100.0% | Sold out |
| Financial Advisory Service, Inc. | 0 | $0 | 0.00% | −8,549−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −2,770−100.0% | Sold out |
| Signet Financial Management, LLC | 0 | $0 | 0.00% | −1,607−100.0% | Sold out |
| Ancora Advisors, LLC | 0 | $0 | 0.00% | −550−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −199−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −23−100.0% | Sold out |
| Centerpoint Advisors, LLC | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Meeder Asset Management Inc | 0 | $0 | 0.00% | −4−100.0% | Sold out |